Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • USA
  • New Clinic Portal
    • 13055014948
  • Request Information
  • Part of brands: |
IGENOMIX – With science on your sideIGENOMIX – With science on your side
  • Part of brands: |
  • PATIENT JOURNEY
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A Plus
      • PGT-A + ERA Synchrony
      • PGT-A
      • PGT-SR
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
  • Kit Request
  • Genetic Counseling
  • Coverage
  • Education
    • Videos
    • Webinars
  • ACADEMY
  • About us
    • Igenomix Research
    • About Igenomix
  • Diagnostics
Genetic Solutions > ERA

ERA® Endometrial Receptivity Analysis

Maximize the chances of pregnancy without losing valuable embryos

  • Technical Overview
  • Documentation
  • Scientific evidence
I'm not a health specialist

ERA is the only endometrial receptivity test supported by an RCT

3 in every 10 women
have a displaced window of implantation**

Download ERA RCT Oral Presentation ASRM 2019

Are you interested?

Request information

Overview

  • ERA®
  • Benefits
  • Indications

What is the ERA® (Endometrial Receptivity Analysis) test?

  • ERA® test, developed and patented by Igenomix (PCT/ ES2009/000386), is a test designed to evaluate endometrial receptivity.  
  • ERA® is the first diagnostic test that determines each woman’s unique personalized embryo transfer timing, therefore synchronizing the embryo transfer with the individualized window of implantation.

What is the procedure?

Why choose ERA®?

Launched in 2011, ERA was the first test of its kind, revolutionizing endometrial diagnostics and laying the foundation for personalized fertility treatment. By identifying a woman’s unique window of implantation, it enables precise embryo transfer timing to optimize IVF success. Backed by robust clinical evidence, ERA remains the most advanced and trusted endometrial receptivity test available.

1. Scientifically proven and well trusted

ERA is a proven solution for patients with RIF, powered by the most scientific publications and the highest clinical success rates compared to any other endometrial receptivity test in the market. In fact, ERA is the only endometrial receptivity test backed by an RCT*. This RCT, involving 320 patients with RIF, demonstrated significantly improved reproductive outcomes—including nearly double the live birth rates—for patients who used ERA in combination with PGT-A, compared to those who used PGT-A alone.

2. Precision timing for embryo transfer, maximizing your chances of success

Powered by AI, the ERA algorithm is not only based upon the endometrial biopsy data from over 200,000 women but integrates clinical outcomes from personalized embryo transfers guided by its results. Combining this with the most comprehensive gene panel available (248 genes), ERA delivers the most precise transcriptomic profiling and personalized embryo transfer timing—maximizing implantation success.

3. Comprehensive support & expertise

Backed by a global team of endometrial experts, ERA is the trusted endometrial receptivity test used by over 3,000 clinics worldwide. Our comprehensive support network includes world-class scientific advisors, dedicated endometrial specialists, genetic counsellors, and in-house clinicians—providing expert guidance to clinics and patients every step of the way.

* 2024 Barbakadze et al. Cureus 16(6): e62949. DOI 10.7759/cureus.62949

Who should use ERA® Endometrial Receptivity Analysis test?

  • ERA® test is indicated for patients with recurrent implantation failure.

When is the second endometrial biopsy needed?

90 % of cases don’t need a second biopsy. The second biopsy is only required under two circumstances:

  • Patients with a “Pre-receptive” result needing 2 more days with progesterone.
  • Patients with a “Post-receptive” result.

Test limitations

Documentation

  • ERA® Specialist's documents

Clinical Sheets

Download

Brochure

Download

Publications List

Download

EndomeTRIO Manual

Download

RCT Key Findings

Download

Retraction of a Meta Analysis

Download

Scientific evidence

References:

* Barbakadze et al., Assessment of theRole of Endometrial ReceptivityAnalysis in Enhancing AssistedReproductive Technology Outcomesfor Advanced-Age Patients. Cureus vol.16,6 e62949. 23 Jun. 2024,doi:10.7759/cureus.62949.

Key Studies:

Visit the ERA insight Hub – International to download the complete ERA Publication List and explore all related studies.

  • Igenomix
  • Independent

A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature.

Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, Simón C.

Fertil Steril. 2011 Jan;95(1):50-60, 60.e1-15. doi: 10.1016/j.fertnstert.2010.04.063. Epub 2010 Jul 8.

PMID:20619403

The accuracy and reproducibility of the endometrial receptivity array is superior to histology as a diagnostic method for endometrial receptivity.

Díaz-Gimeno P, Ruiz-Alonso M, Blesa D, Bosch N, Martínez-Conejero JA, Alamá P, Garrido N, Pellicer A, Simón C.

Fertil Steril. 2013 Feb;99(2):508-17. doi: 10.1016/j.fertnstert.2012.09.046. Epub 2012 Oct 23.

PMID:23102856

The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure.

Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, Carrera J, Vilella F, Pellicer A, Simón C.

Fertil Steril. 2013 Sep;100(3):818-24. doi: 10.1016/j.fertnstert.2013.05.004. Epub 2013 Jun 4.

PMID:23756099

The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure.

Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, Carrera J, Vilella F, Pellicer A, Simón C.

Fertil Steril. 2013 Sep;100(3):818-24. doi: 10.1016/j.fertnstert.2013.05.004. Epub 2013 Jun 4.

PMID:23756099

What a difference two days make: “personalized” embryo transfer (pET) paradigm: a case report and pilot study.

Ruiz-Alonso M, Galindo N, Pellicer A, Simón C.

Hum Reprod. 2014 Jun;29(6):1244-7. doi: 10.1093/humrep/deu070. Epub 2014 Apr 15.

PMID:24737781

What a difference two days make: “personalized” embryo transfer (pET) paradigm: a case report and pilot study.

Ruiz-Alonso M, Galindo N, Pellicer A, Simón C.

Hum Reprod. 2014 Jun;29(6):1244-7. doi: 10.1093/humrep/deu070. Epub 2014 Apr 15.

PMID:24737781

Timing the window of implantation by nucleolar channel system prevalence matches the accuracy of the endometrial receptivity array.

Nejat EJ, Ruiz-Alonso M, Simón C, Meier UT.

Fertil Steril. 2014 Nov;102(5):1477-81. doi: 10.1016/j.fertnstert.2014.07.1254. Epub 2014 Sep 17.

PMID25241377

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.

Bermejo A, Cerrillo M, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, Garcia-Velasco JA.

Fertil Steril. 2014 Jan;101(1):138-146.e3. doi: 10.1016/j.fertnstert.2013.09.033. Epub 2013 Oct 29.

PMID:24182413

Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study.

Garcia-Velasco JA, Fassbender A, Ruiz-Alonso M, Blesa D, D’Hooghe T, Simon C.

Reprod Biomed Online. 2015 Nov;31(5):647-54. doi: 10.1016/j.rbmo.2015.07.014. Epub 2015 Aug 11.

PMID:26385059

Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: a randomized clinical trial.

Strug MR, Su R, Young JE, Dodds WG, Shavell VI, Díaz-Gimeno P, Ruíz-Alonso M, Simón C, Lessey BA, Leach RE, Fazleabas AT.

Hum Reprod. 2016 Jul;31(7):1552-61. doi: 10.1093/humrep/dew080. Epub 2016 Apr 26.

PMID:27122490

Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis.

Comstock IA, Diaz-Gimeno P, Cabanillas S, Bellver J, Sebastian-Leon P, Shah M, Schutt A, Valdes CT, Ruiz-Alonso M, Valbuena D, Simon C, Lathi RB.

Fertil Steril. 2017 Mar;107(3):740-748.e2. doi: 10.1016/j.fertnstert.2016.11.009. Epub 2016 Dec 2.

PMID:27919438

Window of implantation transcriptomic stratification reveals different endometrial subsignatures associated with live birth and biochemical pregnancy.

Díaz-Gimeno P, Ruiz-Alonso M, Sebastian-Leon P, Pellicer A, Valbuena D, Simón C.

Fertil Steril. 2017 Oct;108(4):703-710.e3. doi: 10.1016/j.fertnstert.2017.07.007. Epub 2017 Aug 30.

PMID:28863933

Inter-cycle consistency versus test compliance in endometrial receptivity analysis test.

Stankewicz T, Valbuena D, Ruiz-Alonso M.

J Assist Reprod Genet. 2018 May 26. doi: 10.1007/s10815-018-1212-7

Effect of mifepristone on the transcriptomic signature of endometrial receptivity.

von Grothusen C, Lalitkumar PG, Ruiz-Alonso M, Boggavarapu NR, Navarro R, Miravet-Valenciano J, Gemzell-Danielsson K, Simon C.

Hum Reprod. 2018 Aug 22. doi: 10.1093/humrep/dey272. [Epub ahead of print] PMID: 30137464

Live birth after embryo transfer in an unresponsive thin endometrium.

  1. Cruz, J. Bellver.

Gynecol Endocrinol. 2014 Jul;30(7):481-4. doi: 10.3109/09513590.2014.900747. Epub 2014 Mar 20.

Endometrial receptivity array: Clinical application.

Mahajan N.

J Hum Reprod Sci. 2015 Jul-Sep;8(3):121-9. doi: 10.4103/0974-1208.165153. Review.

PMID:26538853

Efficacy of the endometrial receptivity array for repeated implantation failure in Japan: A retrospective, two-centers study.

Hashimoto T, Koizumi M, Doshida M, Toya M, Sagara E, Oka N, Nakajo Y, Aono N, Igarashi H, Kyono K.

Reprod Med Biol. 2017 Jun 27;16(3):290-296. doi: 10.1002/rmb2.12041. eCollection 2017 Jul.

PMID:29259480

The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers.

Tan J, Kan A, Hitkari J, Taylor B, Tallon N, Warraich G, Yuzpe A, Nakhuda G.

J Assist Reprod Genet. 2018 Jan 11. doi: 10.1007/s10815-017-1112-2.

PMID:29327111

The Reproductive Outcomes for the Infertile Patients with Recurrent Implantation Failures May Be Improved by Endometrial Receptivity Array Test.

Ota, T., Funabiki, M., Tada, Y., Karita, M., Hayashi, T., Maeda, K. et al.

Journal of Medical Cases. 2019; 10(5), 138-140. doi: https://doi.org/10.14740/jmc3282

Why results of endometrial receptivity assay testing should not be discounted in recurrent implantation failure?
Simrandeep K., Padmaja N. The Onco Fertility Journal. 2019; 2(1): 46-49.

Personalized Embryo Transfer Helps in Improving In vitro Fertilization/ICSI Outcomes in Patients with Recurrent Implantation Failure.

Patel JA, Patel AJ, Banker JM, Shah SI, Banker MR. J Hum Reprod Sci. 2019; 12(1):59-66. doi: 10.4103/jhrs.JHRS_74_18.

Endometrial Receptivity Analysis – a tool to increase an implantation rate in assisted reproduction.

Hromadová L; Tokareva I; Veselá K; Trávník P; Veselý J. Ceska Gynekol. 2019; 84(3): 177-183.

Correlation between plasmatic progesterone, endometrial receptivity genetic assay and implantation rates in frozen-thawed transferred euploid embryos. A multivariate analysis.

Barrenetxea G, Romero I, Celis R, Abio A, Bilbao M, Barrenetxea J. Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:192-197.

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide we investigate human reproduction to change the lives of couples who are trying to conceive.

Other services

EndomeTRIO

A new dimension of endometrial health to improve your reproductive prognosis More information

EMMA

Evaluates the endometrium at the microbiological level

More information

ALICE

Detects the bacteria causing chronic endometritis

More information

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

Download ERA RCT Oral Presentation ASRM 2019

[gravityform id=6 title=false description=false ajax=true tabindex=49]

WE GUIDE YOU

Fertility

OUR SERVICES

For Health Specialists
For Patients

ABOUT US

About Igenomix
Contact
Work with us
Quality

FOLLOW IGENOMIX

 

*CAP accreditation applies to the LA lab.

 

  +1 (305) 501-4948 
  Email us                Request Medical Records  
 
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Language

[2025] © Igenomix Privacy policy & cookies policy Quality policy Terms & conditions User Feedback

Request Information

Copyright 2025 © UX Themes
  • PATIENT JOURNEY
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A Plus
      • PGT-A + ERA Synchrony
      • PGT-A
      • PGT-SR
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
  • Kit Request
  • Genetic Counseling
  • Coverage
  • Education
    • Videos
    • Webinars
  • ACADEMY
  • About us
    • Igenomix Research
    • About Igenomix
  • Diagnostics
  • USA
  • New Clinic Portal
Free Call Contact us